BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19653083)

  • 41. MP4, a new nonvasoactive PEG-Hb conjugate.
    Vandegriff KD; Malavalli A; Wooldridge J; Lohman J; Winslow RM
    Transfusion; 2003 Apr; 43(4):509-16. PubMed ID: 12662285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of Dimeric αβ Subunit Exchange between PEGylated and Native Hemoglobins (α
    Matsuhira T; Kure T; Yamamoto K; Sakai H
    Biomacromolecules; 2018 Aug; 19(8):3412-3420. PubMed ID: 29952544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters.
    Wettstein R; Tsai AG; Erni D; Winslow RM; Intaglietta M
    Crit Care Med; 2003 Jun; 31(6):1824-30. PubMed ID: 12794426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resuscitation from hemorrhagic shock with MalPEG-albumin: comparison with MalPEG-hemoglobin.
    Wettstein R; Cabrales P; Erni D; Tsai AG; Winslow RM; Intaglietta M
    Shock; 2004 Oct; 22(4):351-7. PubMed ID: 15377891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isovolemic exchange transfusion with increasing concentrations of low oxygen affinity hemoglobin solution limits oxygen delivery due to vasoconstriction.
    Cabrales P; Tsai AG; Intaglietta M
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2212-8. PubMed ID: 18835914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4).
    Drobin D; Kjellstrom BT; Malm E; Malavalli A; Lohman J; Vandegriff KD; Young MA; Winslow RM
    J Appl Physiol (1985); 2004 May; 96(5):1843-53. PubMed ID: 14729723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformation of the Poly(ethylene Glycol) Chains in DiPEGylated Hemoglobin Specifically Probed by SANS: Correlation with PEG Length and in Vivo Efficiency.
    Le Cœur C; Combet S; Carrot G; Busch P; Teixeira J; Longeville S
    Langmuir; 2015 Aug; 31(30):8402-10. PubMed ID: 26153251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of pegylated hamster red blood cells on microcirculation.
    Chen PC; Huang W; Stassinopoulos A; Cheung AT
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(4):295-309. PubMed ID: 18649167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of polyethylene glycol conjugated bovine hemoglobin in both top-load and exchange transfusion rat models.
    Conover CD; Linberg R; Gilbert CW; Shum KL; Shorr RG
    Artif Organs; 1997 Oct; 21(10):1066-75. PubMed ID: 9335363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Encapsulation of hemoglobin inside liposomes surface conjugated with poly(ethylene glycol) attenuates their reactions with gaseous ligands and regulates nitric oxide dependent vasodilation.
    Rameez S; Guzman N; Banerjee U; Fontes J; Paulaitis ME; Palmer AF; Patel RP; Honavar J
    Biotechnol Prog; 2012; 28(3):636-45. PubMed ID: 22467599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension.
    Sakai H; Hara H; Yuasa M; Tsai AG; Takeoka S; Tsuchida E; Intaglietta M
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H908-15. PubMed ID: 10993749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Balance between vasoconstriction and enhanced oxygen delivery.
    Cabrales P; Tsai AG; Intaglietta M
    Transfusion; 2008 Oct; 48(10):2087-95. PubMed ID: 18631171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophoretic analysis of PEGylated hemoglobin-based blood substitutes.
    Ronda L; Pioselli B; Bruno S; Faggiano S; Mozzarelli A
    Anal Biochem; 2011 Jan; 408(1):118-23. PubMed ID: 20816741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PEGylation of an artificial O2 and CO receptor: synthesis, characterisation and pharmacokinetic study.
    Ueda T; Kitagishi H; Kano K
    Org Biomol Chem; 2012 Jun; 10(22):4337-47. PubMed ID: 22473746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of a Novel PEGylation Site on a Putative Haemoglobin-Based Oxygen Carrier.
    Cooper CE; Bird M; Sheng X; Simons M; Ronda L; Mozzarelli A; Reeder BJ
    Adv Exp Med Biol; 2022; 1395():295-299. PubMed ID: 36527652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood substitutes.
    Palmer AF; Intaglietta M
    Annu Rev Biomed Eng; 2014 Jul; 16():77-101. PubMed ID: 24819476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extreme hemodilution with PEG-hemoglobin vs. PEG-albumin.
    Cabrales P; Tsai AG; Winslow RM; Intaglietta M
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2392-400. PubMed ID: 16024576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CO binding improves the structural, functional, physical and anti-oxidation properties of the PEGylated hemoglobin.
    Wang Q; Hu T; Sun L; Ji S; Zhao D; Liu J; Ma G; Su Z
    Artif Cells Nanomed Biotechnol; 2015 Feb; 43(1):18-25. PubMed ID: 24641771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.
    Vandegriff KD; Young MA; Lohman J; Bellelli A; Samaja M; Malavalli A; Winslow RM
    Br J Pharmacol; 2008 Aug; 154(8):1649-61. PubMed ID: 18536756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of extreme hemodilution with hemoglobin-based O2 carriers on microvascular pressure.
    Cabrales P; Tsai AG; Winslow RM; Intaglietta M
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2146-53. PubMed ID: 15637119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.